View Source

Mol Cancer Res. 2009 Feb;7(2):157-67. Epub 2009 Feb 10. (PMID: 19208739)

[ Differential expression of genes mapping to recurrently abnormal chromosomal regions characterize neuroblastic tumours with distinct ploidy status|http://www.ncbi.nlm.nih.gov/pubmed/18700951?ordinalpos=13&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum]

BMC Med Genomics. 2008 Aug 13;1:36. (PMID: 18700951)
A luminal breast cancer genome atlas: progress and barriers

J Steroid Biochem Mol Biol. 2007 Aug-Sep;106(1-5):125-9. Epub 2007 May 24. (PMID: 17826627)
A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer

N Engl J Med. 2006 Aug 10;355(6):570-80. (PMID: 16899777)
Microarray data analysis in neoadjuvant biomarker studies in estrogen receptor-positive breast cancer

Breast Cancer Research 2010, 12:112 (doi:10.1186/bcr2616) (PMID: 20804563)
Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia

Blood, 1 July 2010, Vol. 115, No. 26, pp. 5312-5321 (PMID: 20139093)
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

Nature Volume:464, Pages:1367-1370, 29 April 2010, (DOI:doi:10.1038/nature08900) (PMID: 20200518)